These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

171 related items for PubMed ID: 11326678

  • 1. Prognostic relevance of serum vascular endothelial growth factor in ovarian cancer.
    Oehler MK, Caffier H.
    Anticancer Res; 2000; 20(6D):5109-12. PubMed ID: 11326678
    [Abstract] [Full Text] [Related]

  • 2. Serum vascular endothelial growth factor in epithelial ovarian neoplasms: correlation with patient survival.
    Chen CA, Cheng WF, Lee CN, Chen TM, Kung CC, Hsieh FJ, Hsieh CY.
    Gynecol Oncol; 1999 Aug; 74(2):235-40. PubMed ID: 10419737
    [Abstract] [Full Text] [Related]

  • 3. Soluble vascular endothelial growth factor levels in patients with primary colorectal carcinoma. The Danish RANX05 Colorectal Cancer Study Group.
    Werther K, Christensen IJ, Brünner N, Nielsen HJ.
    Eur J Surg Oncol; 2000 Nov; 26(7):657-62. PubMed ID: 11078612
    [Abstract] [Full Text] [Related]

  • 4. Are angiogenic factors, cytokines, and soluble adhesion molecules prognostic factors in patients with renal cell carcinoma?
    Dosquet C, Coudert MC, Lepage E, Cabane J, Richard F.
    Clin Cancer Res; 1997 Dec; 3(12 Pt 1):2451-8. PubMed ID: 9815646
    [Abstract] [Full Text] [Related]

  • 5. [Clinical significance of vascular endothelial growth factor in sera of patients with gynaecological malignant tumors].
    Peng XP, Li JD, Li MD, Ye XM, Yan WC.
    Ai Zheng; 2002 Feb; 21(2):181-5. PubMed ID: 12479072
    [Abstract] [Full Text] [Related]

  • 6. Serum preoperative vascular endothelial growth factor (VEGF) in epithelial ovarian cancer: relationship with prognostic variables and clinical outcome.
    Gadducci A, Ferdeghini M, Fanucchi A, Annicchiarico C, Ciampi B, Prontera C, Genazzani AR.
    Anticancer Res; 1999 Feb; 19(2B):1401-5. PubMed ID: 10365113
    [Abstract] [Full Text] [Related]

  • 7. Vascular endothelial growth factor in the sera and effusions of patients with malignant and nonmalignant disease.
    Kraft A, Weindel K, Ochs A, Marth C, Zmija J, Schumacher P, Unger C, Marmé D, Gastl G.
    Cancer; 1999 Jan 01; 85(1):178-87. PubMed ID: 9921991
    [Abstract] [Full Text] [Related]

  • 8. Diagnostic value of serum VEGF in women with ovarian tumors.
    Oehler MK, Caffier H.
    Anticancer Res; 1999 Jan 01; 19(4A):2519-22. PubMed ID: 10470186
    [Abstract] [Full Text] [Related]

  • 9. Serum concentrations of vascular endothelial growth factor in vulvar cancer.
    Hefler L, Tempfer C, Obermair A, Frischmuth K, Sliutz G, Reinthaller A, Leodolter S, Kainz C.
    Clin Cancer Res; 1999 Oct 01; 5(10):2806-9. PubMed ID: 10537345
    [Abstract] [Full Text] [Related]

  • 10. Vascular endothelial growth factor (VEGF)--a valuable serum tumour marker in patients with colorectal cancer?
    Broll R, Erdmann H, Duchrow M, Oevermann E, Schwandner O, Markert U, Bruch HP, Windhövel U.
    Eur J Surg Oncol; 2001 Feb 01; 27(1):37-42. PubMed ID: 11237490
    [Abstract] [Full Text] [Related]

  • 11. [Study on serum vascular endothelial growth factor level in ovarian malignant tumors].
    Li L, Wang LM, Zhang W, Zhang JQ, Song HL, Yao DS, Tang Y, Chen XQ, Yang ZH.
    Zhonghua Fu Chan Ke Za Zhi; 2003 Feb 01; 38(2):72-6. PubMed ID: 12783691
    [Abstract] [Full Text] [Related]

  • 12. Serum vascular endothelial growth factor is often elevated in disseminated cancer.
    Salven P, Mänpää H, Orpana A, Alitalo K, Joensuu H.
    Clin Cancer Res; 1997 May 01; 3(5):647-51. PubMed ID: 9815732
    [Abstract] [Full Text] [Related]

  • 13. Preoperative serum vascular endothelial growth factor levels: significance in ovarian cancer.
    Cooper BC, Ritchie JM, Broghammer CL, Coffin J, Sorosky JI, Buller RE, Hendrix MJ, Sood AK.
    Clin Cancer Res; 2002 Oct 01; 8(10):3193-7. PubMed ID: 12374688
    [Abstract] [Full Text] [Related]

  • 14. The potential clinical relevance of serum vascular endothelial growth factor (VEGF) and VEGF-C in recurrent papillary thyroid carcinoma.
    Yu XM, Lo CY, Lam AK, Lang BH, Leung P, Luk JM.
    Surgery; 2008 Dec 01; 144(6):934-40; discussion 940-1. PubMed ID: 19041000
    [Abstract] [Full Text] [Related]

  • 15. Prognostic significance of plasma vascular endothelial growth factor levels in patients with hormone-refractory prostate cancer treated on Cancer and Leukemia Group B 9480.
    George DJ, Halabi S, Shepard TF, Vogelzang NJ, Hayes DF, Small EJ, Kantoff PW, Cancer and Leukemia Group B 9480.
    Clin Cancer Res; 2001 Jul 01; 7(7):1932-6. PubMed ID: 11448906
    [Abstract] [Full Text] [Related]

  • 16. Vascular endothelial growth factor as prognostic factor in renal cell carcinoma.
    Jacobsen J, Rasmuson T, Grankvist K, Ljungberg B.
    J Urol; 2000 Jan 01; 163(1):343-7. PubMed ID: 10604387
    [Abstract] [Full Text] [Related]

  • 17. [Correlation of preoperative serum vascular endothelial growth factor level with CA125 level in patients with epithelial ovarian cancer and its prognostic value].
    Tan XJ, Lang JH, Shen K, Wang L, Wu M, Xu XY.
    Zhonghua Fu Chan Ke Za Zhi; 2008 Jan 01; 43(1):9-12. PubMed ID: 18366924
    [Abstract] [Full Text] [Related]

  • 18. Preoperative serum vascular endothelial growth factor as a prognostic parameter in ovarian cancer.
    Hefler LA, Zeillinger R, Grimm C, Sood AK, Cheng WF, Gadducci A, Tempfer CB, Reinthaller A.
    Gynecol Oncol; 2006 Nov 01; 103(2):512-7. PubMed ID: 16750560
    [Abstract] [Full Text] [Related]

  • 19. [Association between elevated serum VEGF and polarographically measured tumor hypoxia in head and neck carcinomas].
    Becker A, Stadler P, Krause U, Utzig D, Hänsgen G, Lautenschläger C, Rath FW, Molls M, Dunst J.
    Strahlenther Onkol; 2001 Apr 01; 177(4):182-8. PubMed ID: 11370552
    [Abstract] [Full Text] [Related]

  • 20. Prognostic value of plasma vascular endothelial growth factor in patients with colorectal cancer.
    Nakayama Y, Sako T, Shibao K, Okazaki K, Rempo N, Onitsuka K, Minagawa N, Akahane K, Nagashima N, Nagata N, Itoh H.
    Anticancer Res; 2002 Apr 01; 22(4):2437-42. PubMed ID: 12174940
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.